Subchronic Cannabidiol (CBD) Treatment During the Silent Period Fails to Prevent Increased Seizure Susceptibility Following Lithium-Pilocarpine-Induced Status Epilepticus.

Gómez CT, Fernández F, Jara A, Borda N, Moscovicz F, Yauri-Huaman Y, Caceres-Robles R, Pacheco-Otalora LF, Lazarowski A, Auzmendi J

Open source

DOI: 10.3390/brainsci16080851
Published: 2026 Aug 11
Container: Brain sciences
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/brainsci16080851,
  title = {Subchronic Cannabidiol (CBD) Treatment During the Silent Period Fails to Prevent Increased Seizure Susceptibility Following Lithium-Pilocarpine-Induced Status Epilepticus.},
  author = {Gómez CT and Fernández F and Jara A and Borda N and Moscovicz F and Yauri-Huaman Y and Caceres-Robles R and Pacheco-Otalora LF and Lazarowski A and Auzmendi J},
  year = {2026},
  journal = {Brain sciences},
  doi = {10.3390/brainsci16080851},
  url = {https://doi.org/10.3390/brainsci16080851}
}

RIS

TY  - JOUR
TI  - Subchronic Cannabidiol (CBD) Treatment During the Silent Period Fails to Prevent Increased Seizure Susceptibility Following Lithium-Pilocarpine-Induced Status Epilepticus.
AU  - Gómez CT
AU  - Fernández F
AU  - Jara A
AU  - Borda N
AU  - Moscovicz F
AU  - Yauri-Huaman Y
AU  - Caceres-Robles R
AU  - Pacheco-Otalora LF
AU  - Lazarowski A
AU  - Auzmendi J
PY  - 2026
JO  - Brain sciences
DO  - 10.3390/brainsci16080851
UR  - https://doi.org/10.3390/brainsci16080851
ER  -

APA

CT, G., F, F., A, J., N, B., F, M., Y, Y., R, C., LF, P., A, L., & J, A. (2026). Subchronic Cannabidiol (CBD) Treatment During the Silent Period Fails to Prevent Increased Seizure Susceptibility Following Lithium-Pilocarpine-Induced Status Epilepticus.. Brain sciences. https://doi.org/10.3390/brainsci16080851

Source records

pubmed · retrieved 2026-09-25T16:47:23.630Z
europe-pmc · retrieved 2026-09-25T16:47:23.652Z
doaj · retrieved 2026-09-25T16:47:23.638Z